Wiley.com
Print this page Share

BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease

Varghese John
ISBN: 978-0-470-29342-3
Hardcover
288 pages
March 2010
List Price: US $133.00
Government Price: US $92.12
Enter Quantity:   Buy
BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease (047029342X) cover image
This is a Print-on-Demand title. It will be printed specifically to fill your order. Please allow an additional 10-15 days delivery time. The book is not returnable.

"Overall this book is a timely and comprehensive resource covering developments in BACE-targeted therapeutic agents from infancy to the present time. It will prove to be valuable to researchers working in the AD field, as well as to medicinal chemists seeking to learn more about rational design of aspartyl protease inhibitors." (ChemMedChem, November 2010)

Related Titles

Drug Discovery & Development

GPCR Molecular Pharmacology and Drug Targeting: Shifting Paradigms and New Directions
by Annette Gilchrist (Editor)
Metabolic Syndrome: Underlying Mechanisms and Drug Therapies
by Minghan Wang (Editor)
Pharmaceutical Toxicology in Practice: A Guide to Non-clinical Development
by Alberto Lodola (Editor), Jeanne Stadler (Editor)
Guidebook for Drug Regulatory Submissions
by Sandy Weinberg
Characterization of Impurities and Degradants Using Mass Spectrometry
by Birendra Pramanik (Editor), Mike S. Lee (Editor), Guodong Chen
Drug Truths: Dispelling the Myths About Pharma R & D
by John L. LaMattina
Mass Spectrometry in Drug Metabolism and Disposition: Basic Principles and Applications
by Mike S. Lee (Editor), Mingshe Zhu (Editor)
Back to Top